- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD9838
Total 159 results
-
AstraZenecaQuotient SciencesCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
AstraZenecaParexelTerminated
-
AstraZenecaCompletedHepatic ImpairmentUnited States, Bulgaria, Slovakia
-
AstraZenecaActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionUnited States
-
AstraZenecaCompletedHealthy Volunteers | Alzheimer's Disease | Tolerability | Safety | Blood ConcentrationUnited Kingdom
-
AstraZenecaCompletedCystic FibrosisSweden, Russian Federation, United Kingdom, Poland, Denmark, Germany
-
AstraZenecaTerminated
-
AstraZenecaCompletedHER2-negative Breast CancerMexico, United Kingdom, Georgia
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesRussian Federation, Germany
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaRecruitingHematological MalignanciesUnited States, Spain, Korea, Republic of, Italy, China, Japan, Taiwan, Australia, Germany, United Kingdom
-
Massachusetts General HospitalAstraZenecaRecruiting
-
AstraZenecaCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Poland, Germany, Philippines, Ukraine, Japan, United States, Australia, Canada, Slovakia, Taiwan, Russian Federation
-
AstraZenecaActive, not recruitingAdvanced Solid TumoursUnited States, France, Spain
-
AstraZenecaTerminatedHeart FailureDenmark, Finland, Netherlands, United States, Sweden
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
AstraZenecaParexelCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, Denmark, Finland, Netherlands, Norway
-
Mayo ClinicNational Center for Advancing Translational Sciences (NCATS)Completed
-
AstraZenecaParexelCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthyUnited Kingdom
-
AstraZenecaCompleted
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research CentreActive, not recruitingSolid Tumour Refractory to Conventional TreatmentUnited Kingdom
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States, Denmark, Italy, United Kingdom, Canada, Germany, Turkey, Argentina, South Africa, Spain, Poland, Bulgaria, Mexico, Netherlands
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Cancer Research UK; National Institute for Health Research...Completed
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited States
-
AstraZenecaCompletedHealthy VolunteersSweden
-
AstraZenecaCompleted
-
AstraZenecaCompletedBronchiectasisUnited Kingdom, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Romania, Ukraine, Denmark, Netherlands, Canada
-
AstraZenecaCompleted
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
AstraZenecaQuotient SciencesCompletedER-positive, HER2-negative Breast CancerUnited Kingdom
-
AstraZenecaCompletedThe Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled AllergenAllergic AsthmaUnited Kingdom
-
AstraZenecaCompletedHealthy | Allergic RhinitisSweden
-
AstraZenecaWithdrawnPharmacokinetics | PharmacodynamicsSweden
-
AstraZenecaCompletedAllergic RhinitisSweden